お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
969126

塞栓粒子術のBRIC諸国における展望 (~2025年) :動静脈奇形・良性前立腺過形成 (BPH) ・その他治療向け塞栓粒子術

BRIC Embolization Particle Procedures Outlook to 2025 - Embolization Particle Procedures to treat Arteriovenous Malformations, Embolization Particle Procedures to treat Benign prostatic hyperplasia and Others

出版日: | 発行: GlobalData | ページ情報: 英文 132 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.84円
塞栓粒子術のBRIC諸国における展望 (~2025年) :動静脈奇形・良性前立腺過形成 (BPH) ・その他治療向け塞栓粒子術
出版日: 2020年11月01日
発行: GlobalData
ページ情報: 英文 132 Pages
納期: 即納可能 即納可能とは
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、BRIC諸国における塞栓粒子術市場について調査し、国および疾患別による塞栓粒子術に関連する重要な情報とデータを提供しています。

目次

第1章 目次

第2章 イントロダクション

第3章 塞栓粒子術:BRIC諸国

  • 塞栓粒子術:BRIC諸国

第4章 塞栓粒子術:ブラジル

  • 塞栓粒子術:ブラジル
    • 動静脈奇形治療向け塞栓粒子術
    • 良性前立腺肥大症 (BPH) 治療向け塞栓粒子術
    • 転移性肝疾患を伴う結腸直腸癌治療向け塞栓粒子術
    • 肝細胞癌治療向け塞栓粒子術
    • 肝内胆管癌治療向け塞栓粒子術
    • 転移性肝疾患を伴う神経内分泌腫瘍治療向け塞栓粒子術
    • 転移性肝疾患を伴う他の腫瘍治療向け塞栓粒子術
    • 腎細胞癌治療向け塞栓粒子術
    • 子宮筋腫治療向け塞栓粒子術

第5章 塞栓粒子術:ロシア

第6章 塞栓粒子術:インド

第7章 塞栓粒子術:中国

第8章 付録

  • 調査手法
    • カバレッジ
    • 2次調査
    • 1次調査
    • 市場のモデリングと予測
    • 企業シェア分析
    • 流通シェア分析
    • ベンチマーク
  • GlobalDataコンサルティング
  • お問い合わせ
  • 免責事項
図表

List of Tables

List of Tables

  • Table 1: Embolization Particle Procedures, BRIC, 2015-2025
  • Table 2: Embolization Particle Procedures, BRIC, 2015-2020
  • Table 3: Embolization Particle Procedures, BRIC, 2021-2025
  • Table 4: Embolization Particle Procedures, Brazil, 2015-2020
  • Table 5: Embolization Particle Procedures, Brazil, 2021-2025
  • Table 6: Embolization Particle Procedures to treat Arteriovenous Malformations, Brazil, 2015-2020
  • Table 7: Embolization Particle Procedures to treat Arteriovenous Malformations, Brazil, 2021-2025
  • Table 8: Embolization Particle Procedures to treat Benign prostatic hyperplasia, Brazil, 2015-2020
  • Table 9: Embolization Particle Procedures to treat Benign prostatic hyperplasia, Brazil, 2021-2025
  • Table 10: Embolization Particle Procedures to treat Colorectal Cancer with Metastatic Liver Disease, Brazil, 2015-2020
  • Table 11: Embolization Particle Procedures to treat Colorectal Cancer with Metastatic Liver Disease, Brazil, 2021-2025
  • Table 12: Embolization Particle Procedures to treat Hepatocellular Carcinoma, Brazil, 2015-2020
  • Table 13: Embolization Particle Procedures to treat Hepatocellular Carcinoma, Brazil, 2021-2025
  • Table 14: Embolization Particle Procedures to treat Intrahepatic cholangiocarcinoma, Brazil, 2015-2020
  • Table 15: Embolization Particle Procedures to treat Intrahepatic cholangiocarcinoma, Brazil, 2021-2025
  • Table 16: Embolization Particle Procedures to treat Neuroendocrine tumors with Metastatic Liver Disease, Brazil, 2015-2020
  • Table 17: Embolization Particle Procedures to treat Neuroendocrine tumors with Metastatic Liver Disease, Brazil, 2021-2025
  • Table 18: Embolization Particle Procedures to treat Other tumors with Metastatic Liver Disease, Brazil, 2015-2020
  • Table 19: Embolization Particle Procedures to treat Other tumors with Metastatic Liver Disease, Brazil, 2021-2025
  • Table 20: Embolization Particle Procedures to treat Renal Cell Carcinoma, Brazil, 2015-2020
  • Table 21: Embolization Particle Procedures to treat Renal Cell Carcinoma, Brazil, 2021-2025
  • Table 22: Embolization Particle Procedures to treat Uterine Fibroids, Brazil, 2015-2020
  • Table 23: Embolization Particle Procedures to treat Uterine Fibroids, Brazil, 2021-2025
  • Table 24: Embolization Particle Procedures, Russia, 2015-2020
  • Table 25: Embolization Particle Procedures, Russia, 2021-2025
  • Table 26: Embolization Particle Procedures to treat Arteriovenous Malformations, Russia, 2015-2020
  • Table 27: Embolization Particle Procedures to treat Arteriovenous Malformations, Russia, 2021-2025
  • Table 28: Embolization Particle Procedures to treat Benign prostatic hyperplasia, Russia, 2015-2020
  • Table 29: Embolization Particle Procedures to treat Benign prostatic hyperplasia, Russia, 2021-2025
  • Table 30: Embolization Particle Procedures to treat Colorectal Cancer with Metastatic Liver Disease, Russia, 2015-2020
  • Table 31: Embolization Particle Procedures to treat Colorectal Cancer with Metastatic Liver Disease, Russia, 2021-2025
  • Table 32: Embolization Particle Procedures to treat Hepatocellular Carcinoma, Russia, 2015-2020
  • Table 33: Embolization Particle Procedures to treat Hepatocellular Carcinoma, Russia, 2021-2025
  • Table 34: Embolization Particle Procedures to treat Intrahepatic cholangiocarcinoma, Russia, 2015-2020
  • Table 35: Embolization Particle Procedures to treat Intrahepatic cholangiocarcinoma, Russia, 2021-2025
  • Table 36: Embolization Particle Procedures to treat Neuroendocrine tumors with Metastatic Liver Disease, Russia, 2015-2020
  • Table 37: Embolization Particle Procedures to treat Neuroendocrine tumors with Metastatic Liver Disease, Russia, 2021-2025
  • Table 38: Embolization Particle Procedures to treat Other tumors with Metastatic Liver Disease, Russia, 2015-2020
  • Table 39: Embolization Particle Procedures to treat Other tumors with Metastatic Liver Disease, Russia, 2021-2025
  • Table 40: Embolization Particle Procedures to treat Renal Cell Carcinoma, Russia, 2015-2020
  • Table 41: Embolization Particle Procedures to treat Renal Cell Carcinoma, Russia, 2021-2025
  • Table 42: Embolization Particle Procedures to treat Uterine Fibroids, Russia, 2015-2020
  • Table 43: Embolization Particle Procedures to treat Uterine Fibroids, Russia, 2021-2025
  • Table 44: Embolization Particle Procedures, India, 2015-2020
  • Table 45: Embolization Particle Procedures, India, 2021-2025

List of Figures

List of Figures

  • Figure 1: Embolization Particle Procedures, BRIC, 2015-2025
  • Figure 2: Embolization Particle Procedures, BRIC, 2015-2025
  • Figure 3: Embolization Particle Procedures, Brazil, 2015-2025
  • Figure 4: Embolization Particle Procedures to treat Arteriovenous Malformations, Brazil, 2015-2025
  • Figure 5: Embolization Particle Procedures to treat Benign prostatic hyperplasia, Brazil, 2015-2025
  • Figure 6: Embolization Particle Procedures to treat Colorectal Cancer with Metastatic Liver Disease, Brazil, 2015-2025
  • Figure 7: Embolization Particle Procedures to treat Hepatocellular Carcinoma, Brazil, 2015-2025
  • Figure 8: Embolization Particle Procedures to treat Intrahepatic cholangiocarcinoma, Brazil, 2015-2025
  • Figure 9: Embolization Particle Procedures to treat Neuroendocrine tumors with Metastatic Liver Disease, Brazil, 2015-2025
  • Figure 10: Embolization Particle Procedures to treat Other tumors with Metastatic Liver Disease, Brazil, 2015-2025
  • Figure 11: Embolization Particle Procedures to treat Renal Cell Carcinoma, Brazil, 2015-2025
  • Figure 12: Embolization Particle Procedures to treat Uterine Fibroids, Brazil, 2015-2025
  • Figure 13: Embolization Particle Procedures, Russia, 2015-2025
  • Figure 14: Embolization Particle Procedures to treat Arteriovenous Malformations, Russia, 2015-2025
  • Figure 15: Embolization Particle Procedures to treat Benign prostatic hyperplasia, Russia, 2015-2025
  • Figure 16: Embolization Particle Procedures to treat Colorectal Cancer with Metastatic Liver Disease, Russia, 2015-2025
  • Figure 17: Embolization Particle Procedures to treat Hepatocellular Carcinoma, Russia, 2015-2025
  • Figure 18: Embolization Particle Procedures to treat Intrahepatic cholangiocarcinoma, Russia, 2015-2025
  • Figure 19: Embolization Particle Procedures to treat Neuroendocrine tumors with Metastatic Liver Disease, Russia, 2015-2025
  • Figure 20: Embolization Particle Procedures to treat Other tumors with Metastatic Liver Disease, Russia, 2015-2025
  • Figure 21: Embolization Particle Procedures to treat Renal Cell Carcinoma, Russia, 2015-2025
  • Figure 22: Embolization Particle Procedures to treat Uterine Fibroids, Russia, 2015-2025
  • Figure 23: Embolization Particle Procedures, India, 2015-2025
  • Figure 24: Embolization Particle Procedures to treat Arteriovenous Malformations, India, 2015-2025
  • Figure 25: Embolization Particle Procedures to treat Benign prostatic hyperplasia, India, 2015-2025
  • Figure 26: Embolization Particle Procedures to treat Colorectal Cancer with Metastatic Liver Disease, India, 2015-2025
  • Figure 27: Embolization Particle Procedures to treat Hepatocellular Carcinoma, India, 2015-2025
  • Figure 28: Embolization Particle Procedures to treat Intrahepatic cholangiocarcinoma, India, 2015-2025
  • Figure 29: Embolization Particle Procedures to treat Neuroendocrine tumors with Metastatic Liver Disease, India, 2015-2025
  • Figure 30: Embolization Particle Procedures to treat Other tumors with Metastatic Liver Disease, India, 2015-2025
  • Figure 31: Embolization Particle Procedures to treat Renal Cell Carcinoma, India, 2015-2025
  • Figure 32: Embolization Particle Procedures to treat Uterine Fibroids, India, 2015-2025
  • Figure 33: Embolization Particle Procedures, China, 2015-2025
  • Figure 34: Embolization Particle Procedures to treat Arteriovenous Malformations, China, 2015-2025
  • Figure 35: Embolization Particle Procedures to treat Benign prostatic hyperplasia, China, 2015-2025
  • Figure 36: Embolization Particle Procedures to treat Colorectal Cancer with Metastatic Liver Disease, China, 2015-2025
  • Figure 37: Embolization Particle Procedures to treat Hepatocellular Carcinoma, China, 2015-2025
  • Figure 38: Embolization Particle Procedures to treat Intrahepatic cholangiocarcinoma, China, 2015-2025
  • Figure 39: Embolization Particle Procedures to treat Neuroendocrine tumors with Metastatic Liver Disease, China, 2015-2025
  • Figure 40: Embolization Particle Procedures to treat Other tumors with Metastatic Liver Disease, China, 2015-2025
  • Figure 41: Embolization Particle Procedures to treat Renal Cell Carcinoma, China, 2015-2025
  • Figure 42: Embolization Particle Procedures to treat Uterine Fibroids, China, 2015-2025
目次
Product Code: GDMECR0697PDB

GlobalData's "BRIC Embolization Particle Procedures Outlook to 2025" is a comprehensive databook report, covering key procedures data on the BRIC Embolization Particle Procedures. The databook report provides procedure volumes within segments - Embolization Particle Procedures to treat Arteriovenous Malformations, Embolization Particle Procedures to treat Benign prostatic hyperplasia, Embolization Particle Procedures to treat Colorectal Cancer with Metastatic Liver Disease, Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic cholangiocarcinoma, Embolization Particle Procedures to treat Neuroendocrine tumors with Metastatic Liver Disease, Embolization Particle Procedures to treat Other tumors with Metastatic Liver Disease, Embolization Particle Procedures to treat Renal Cell Carcinoma and Embolization Particle Procedures to treat Uterine Fibroids.

The BRIC Embolization Particle Procedures report provides key information and data on -

  • Procedure volume data for Embolization Particle Procedures related to the country. Data is provided from 2015 to 2025.

Scope

BRIC Embolization Particle Procedures is segmented as follows -

  • Embolization Particle Procedures to treat Arteriovenous Malformations
  • Embolization Particle Procedures to treat Benign prostatic hyperplasia
  • Embolization Particle Procedures to treat Colorectal Cancer with Metastatic Liver Disease
  • Embolization Particle Procedures to treat Hepatocellular Carcinoma
  • Embolization Particle Procedures to treat Intrahepatic cholangiocarcinoma
  • Embolization Particle Procedures to treat Neuroendocrine tumors with Metastatic Liver Disease
  • Embolization Particle Procedures to treat Other tumors with Metastatic Liver Disease
  • Embolization Particle Procedures to treat Renal Cell Carcinoma
  • Embolization Particle Procedures to treat Uterine Fibroids

Reasons to Buy

The BRIC Embolization Particle Procedures report helps you to develop -

  • Business strategies by identifying the key segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Develop investment strategies by identifying the key segments expected to register strong growth in the near future.

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 What Is This Report About?
  • 2.2 Embolization Particle Procedures Segmentation
  • 2.3 Definitions of Procedures Covered in the Report

3 Embolization Particle Procedures, BRIC

  • 3.1 Embolization Particle Procedures, BRIC, 2015-2025
  • 3.2 Embolization Particle Procedures, BRIC, 2015-2025

4 Embolization Particle Procedures, Brazil

  • 4.1 Embolization Particle Procedures, Brazil, 2015-2025
    • 4.1.1 Embolization Particle Procedures to treat Arteriovenous Malformations, Brazil, 2015-2025
    • 4.1.2 Embolization Particle Procedures to treat Benign prostatic hyperplasia, Brazil, 2015-2025
    • 4.1.3 Embolization Particle Procedures to treat Colorectal Cancer with Metastatic Liver Disease, Brazil, 2015-2025
    • 4.1.4 Embolization Particle Procedures to treat Hepatocellular Carcinoma, Brazil, 2015-2025
    • 4.1.5 Embolization Particle Procedures to treat Intrahepatic cholangiocarcinoma, Brazil, 2015-2025
    • 4.1.6 Embolization Particle Procedures to treat Neuroendocrine tumors with Metastatic Liver Disease, Brazil, 2015-2025
    • 4.1.7 Embolization Particle Procedures to treat Other tumors with Metastatic Liver Disease, Brazil, 2015-2025
    • 4.1.8 Embolization Particle Procedures to treat Renal Cell Carcinoma, Brazil, 2015-2025
    • 4.1.9 Embolization Particle Procedures to treat Uterine Fibroids, Brazil, 2015-2025

5 Embolization Particle Procedures, Russia

  • 5.1 Embolization Particle Procedures, Russia, 2015-2025
    • 5.1.1 Embolization Particle Procedures to treat Arteriovenous Malformations, Russia, 2015-2025
    • 5.1.2 Embolization Particle Procedures to treat Benign prostatic hyperplasia, Russia, 2015-2025
    • 5.1.3 Embolization Particle Procedures to treat Colorectal Cancer with Metastatic Liver Disease, Russia, 2015-2025
    • 5.1.4 Embolization Particle Procedures to treat Hepatocellular Carcinoma, Russia, 2015-2025
    • 5.1.5 Embolization Particle Procedures to treat Intrahepatic cholangiocarcinoma, Russia, 2015-2025
    • 5.1.6 Embolization Particle Procedures to treat Neuroendocrine tumors with Metastatic Liver Disease, Russia, 2015-2025
    • 5.1.7 Embolization Particle Procedures to treat Other tumors with Metastatic Liver Disease, Russia, 2015-2025
    • 5.1.8 Embolization Particle Procedures to treat Renal Cell Carcinoma, Russia, 2015-2025
    • 5.1.9 Embolization Particle Procedures to treat Uterine Fibroids, Russia, 2015-2025

6 Embolization Particle Procedures, India

  • 6.1 Embolization Particle Procedures, India, 2015-2025
    • 6.1.1 Embolization Particle Procedures to treat Arteriovenous Malformations, India, 2015-2025
    • 6.1.2 Embolization Particle Procedures to treat Benign prostatic hyperplasia, India, 2015-2025
    • 6.1.3 Embolization Particle Procedures to treat Colorectal Cancer with Metastatic Liver Disease, India, 2015-2025
    • 6.1.4 Embolization Particle Procedures to treat Hepatocellular Carcinoma, India, 2015-2025
    • 6.1.5 Embolization Particle Procedures to treat Intrahepatic cholangiocarcinoma, India, 2015-2025
    • 6.1.6 Embolization Particle Procedures to treat Neuroendocrine tumors with Metastatic Liver Disease, India, 2015-2025
    • 6.1.7 Embolization Particle Procedures to treat Other tumors with Metastatic Liver Disease, India, 2015-2025
    • 6.1.8 Embolization Particle Procedures to treat Renal Cell Carcinoma, India, 2015-2025
    • 6.1.9 Embolization Particle Procedures to treat Uterine Fibroids, India, 2015-2025

7 Embolization Particle Procedures, China

  • 7.1 Embolization Particle Procedures, China, 2015-2025
    • 7.1.1 Embolization Particle Procedures to treat Arteriovenous Malformations, China, 2015-2025
    • 7.1.2 Embolization Particle Procedures to treat Benign prostatic hyperplasia, China, 2015-2025
    • 7.1.3 Embolization Particle Procedures to treat Colorectal Cancer with Metastatic Liver Disease, China, 2015-2025
    • 7.1.4 Embolization Particle Procedures to treat Hepatocellular Carcinoma, China, 2015-2025
    • 7.1.5 Embolization Particle Procedures to treat Intrahepatic cholangiocarcinoma, China, 2015-2025
    • 7.1.6 Embolization Particle Procedures to treat Neuroendocrine tumors with Metastatic Liver Disease, China, 2015-2025
    • 7.1.7 Embolization Particle Procedures to treat Other tumors with Metastatic Liver Disease, China, 2015-2025
    • 7.1.8 Embolization Particle Procedures to treat Renal Cell Carcinoma, China, 2015-2025
    • 7.1.9 Embolization Particle Procedures to treat Uterine Fibroids, China, 2015-2025

8 Appendix

  • 8.1 Research Methodology
    • 8.1.1 Coverage
    • 8.1.2 Secondary Research
    • 8.1.3 Primary Research
    • 8.1.4 Market Modeling and Forecasting
    • 8.1.5 Company Share Analysis
    • 8.1.6 Distribution Share Analysis
    • 8.1.7 Benchmarking
  • 8.2 GlobalData Consulting
  • 8.3 Contact Us
  • 8.4 Disclaimer
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.